Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03709706
Title Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | ESP | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site La Jolla California 92093-0987 United States Details
GSK Investigational Site Sacramento California 95817 United States Details
GSK Investigational Site Stanford California 94305 United States Details
GSK Investigational Site Denver Colorado 80218 United States Details
GSK Investigational Site Hollywood Florida 33021 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Chicago Illinois 60637 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site Lexington Kentucky 40536 United States Details
GSK Investigational Site Baltimore Maryland 21201 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Durham North Carolina 27710 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15232 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Salt Lake City Utah 84112-5550 United States Details
GSK Investigational Site Toronto Ontario M5G 1X6 Canada Details
GSK Investigational Site Montréal Quebec H2X 0A9 Canada Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Groningen 9713 GZ Netherlands Details
GSK Investigational Site Rotterdam 3015 GD Netherlands Details
GSK Investigational Site Utrecht 3584 CX Netherlands Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site London WC1E 6AG United Kingdom Details
GSK Investigational Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field